Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04310007 |
Recruitment Status :
Recruiting
First Posted : March 17, 2020
Last Update Posted : April 12, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Metastatic Lung Non-Squamous Non-Small Cell Carcinoma Recurrent Lung Non-Squamous Non-Small Cell Carcinoma Stage III Lung Cancer AJCC v8 Stage IIIA Lung Cancer AJCC v8 Stage IIIB Lung Cancer AJCC v8 Stage IIIC Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Unresectable Lung Non-Squamous Non-Small Cell Carcinoma | Drug: Cabozantinib S-malate Drug: Docetaxel Drug: Gemcitabine Hydrochloride Drug: Nab-paclitaxel Biological: Nivolumab Drug: Paclitaxel Biological: Ramucirumab | Phase 2 |


PRIMARY OBJECTIVE:
I. To determine whether cabozantinib alone, or the combination of nivolumab and cabozantinib, as compared to standard chemotherapy alone, extends progression-free survival (PFS) for this patient population with non squamous NSCLC.
SECONDARY OBJECTIVES:
I. To evaluate the progression free survival (PFS) and best overall radiographic response rate of the targeted therapy arm of the trial.
II. To determine the overall survival for each arm of the trial. III. To evaluate the best overall radiographic response rate for each arm of the trial.
IV. To evaluate and describe the toxicity profile of monotherapy with cabozantinib, and the combination of nivolumab and cabozantinib in this patient population with non-squamous NSCLC.
EXPLORATORY IMAGING OBJECTIVES:
I. To describe time point tumor response assessment, overall best response, progression-free survival and overall survival using the conventional Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria and the exploratory revised CHOI criteria with all measurements performed by the central review.
II. To compare the progression-free survival using the RECIST1.1 imaging response assessment measurements by site study personnel to those performed by central review.
EXPLORATORY CORRELATIVE OBJECTIVE:
I. To perform correlative biomarker research on tissue and blood biospecimens collected within this trial.
OUTLINE: Patients without known molecular alterations are randomly assigned to 1 of 3 arms. Patients with known molecular alterations are assigned to Arm B.
ARM A: Patients receive cabozantinib S-malate orally (PO) once daily (QD). Cycles repeat every 3 weeks in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit.
ARM B: Patients receive cabozantinib S-malate PO QD and nivolumab intravenously (IV) over 30 minutes on day 1. Cycles repeat every 3 weeks in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit.
ARM C:
STEP 1: Patients receive ramucirumab IV over 30-60 minutes and docetaxel IV over 1 hour on day 1, or docetaxel IV over 1 hour on day 1 or on days 1 and 8, or gemcitabine hydrochloride IV on days 1 and 8, or paclitaxel IV over 3 hours on day 1, or nab-paclitaxel IV over 30 minutes on days 1, 8, and 15. Cycles repeat every 3 weeks in the absence of disease progression or unacceptable toxicity and at the discretion of the treating physician. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit.
STEP 2: Patients receive cabozantinib S-malate PO QD and nivolumab IV over 30 minutes on day 1. Cycles repeat every 3 weeks in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit.
After the completion of study treatment, patients are followed up every 3 months for up to 3 years.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 142 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus Nivolumab Versus Standard Chemotherapy in Patients With Previously Treated Non-Squamous NSCLC |
Actual Study Start Date : | May 22, 2020 |
Estimated Primary Completion Date : | May 1, 2022 |
Estimated Study Completion Date : | May 1, 2022 |

Arm | Intervention/treatment |
---|---|
Experimental: Arm A (cabozantinib S-malate)
Patients receive cabozantinib S-malate PO QD. Cycles repeat every 3 weeks in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit.
|
Drug: Cabozantinib S-malate
Given PO
Other Names:
|
Experimental: Arm B (cabozantinib S-malate, nivolumab)
Patients receive cabozantinib S-malate PO QD and nivolumab IV over 30 minutes on day 1. Cycles repeat every 3 weeks in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit.
|
Drug: Cabozantinib S-malate
Given PO
Other Names:
Biological: Nivolumab Given IV
Other Names:
|
Active Comparator: Arm C (standard chemotherapy,cabozantinib S-malate, nivolumab)
See Detailed Description
|
Drug: Cabozantinib S-malate
Given PO
Other Names:
Drug: Docetaxel Given IV
Other Names:
Drug: Gemcitabine Hydrochloride Given PO
Other Names:
Drug: Nab-paclitaxel Given IV
Other Names:
Biological: Nivolumab Given IV
Other Names:
Drug: Paclitaxel Given IV
Other Names:
Biological: Ramucirumab Given IV
Other Names:
|
- Progression-free survival (PFS) for patient population with non-squamous no-small cell lung cancer (NSCLC) [ Time Frame: After 58 events (From time of randomization to documented disease progression [site review of imaging] or death from any cause, whichever occurs first) ]The final analysis of PFS will be performed when the full information of PFS is reached (i.e., 58 events for each of the two primary comparisons). The two primary comparisons of PFS will each use a logrank test stratified on the randomization stratification factors with a one-sided type I error rate of 10%. Estimates of PFS including medians and confidence intervals, will be calculated using the Kaplan-Meier method. Cox proportional hazards models, stratified, on the same factors, will be used to estimate the treatment hazard ratios. At the final analyses, in the event that both primary PFS comparisons of the combination of nivolumab with cabozantinib and cabozantinib alone versus the standard chemotherapy are statistically significant, PFS will be compared between the two experimental arms (combination of nivolumab with cabozantinib versus [vs.] cabozantinib alone), using a stratified log rank test with a one-sided type I error rate of 10%.
- Overall survival (OS) for each arm [ Time Frame: From time of randomization to documented disease progression (site review of imaging) or death from any cause, whichever occurs first, assessed up to 3 years ]The final analysis of OS will be performed when the full information of PFS is reached (i.e., 58 events for each of the two primary comparisons). OS will be tested in a hierarchical fashion if the primary comparison of PFS between treatment arms is statistically significant, using a log rank test stratified on the randomization stratification factors with a one-sided type I error rate of 10%. Estimates of OS, including medians and confidence intervals, will be calculated using the Kaplan-Meier method. Cox proportional hazards models, stratified, on the same factors, will be used to estimate the treatment hazard ratios. OS will be further tested in a hierarchical fashion if the comparison of PFS between the two experimental arms is statistically significant. Point estimates of all endpoints will be accompanied by the corresponding two-sided 80% confidence intervals. Subset analyses of PFS and OS by treatment arm will be estimated and compared within subsets.
- Best objective response for each arm [ Time Frame: Every 6 weeks for the first year on study, and then every 12 weeks after year one ]Will be evaluated via Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria. Response rates (complete response [CR] + partial response [PR]) and toxicity will be compared using Fisher's exact tests with a one-sided type I error rate of 10%; multivariable logistic regression modeling will be used to adjust for the effect of any covariates that are associated with these categorical outcomes. Modeling procedures will implement backward selection; variables significant at the 0.10 level in the univariate setting will be chosen for inclusion in an initial full model, and at each step the least significant variable will be removed from the model. Only those covariates with p < 0.05 will remain in any final models, unless there are factors identified by the study team as crucial to model interpretation. Point estimates of all endpoints will be accompanied by the corresponding two-sided 80% confidence intervals.
- Toxicity profile of monotherapy with cabozantinib, and the combination of nivolumab and cabozantinib [ Time Frame: Up to 3 years after completion of study treatment ]Will be determined using the Common Terminology Criteria for Adverse Events (CTCAE) criteria. Response rates (complete response [CR] + pathologic response [PR]) and toxicity will be compared using Fisher's exact tests with a one-sided type I error rate of 10%; multivariable logistic regression modeling will be used to adjust for the effect of any covariates that are associated with these categorical outcomes. Modeling procedures will implement backward selection; variables significant at the 0.10 level in the univariate setting will be chosen for inclusion in an initial full model, and at each step the least significant variable will be removed from the model. Only those covariates with p < 0.05 will remain in any final models, unless there are factors identified by the study team as crucial to model interpretation. Point estimates of all endpoints will be accompanied by the corresponding two-sided 80% confidence intervals.
- The RECIST1.1 response at each time point [ Time Frame: Every 6 weeks for the first year on study, and then every 12 weeks after year one ]The measurement of each time point will be performed using the revised CHOI criteria will be only applied to arms A, B, and T, which will include anti-angiogenic therapy. Both the RECIST1.1 and revised CHOI criteria will assess the overall best response as CR, partial PR, stable disease (SD), or progressive disease (PD). Their concordance will be assessed using the weighted Cohen's kappa coefficient (k) with quadratic weights. As a rule of thumb, the level of concordance between the two criteria will be considered poor (k <0), slight (k 0-0.20), fair (k 0.21-0.40), moderate (k 0.41-0.60), substantial (k 0.61-0.80), and almost perfect (k 0.81 - 1).
- Agreement between central view and site review in terms of progression-free survival [ Time Frame: After the completion of study treatment ]The progression status and the progression time will be assessed in agreement. The progression status is a binary measurement and the agreement will be assessed using the Cohen's kappa coefficient. For progression time, will assess the temporal agreement using the method developed by Zeng et al.
- Correlative biomarker research [ Time Frame: After the completion of study treatment ]Correlative biomarker research will be performed on tissue and blood specimens collected within this trial.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- ELIGIBILITY CRITERIA FOR STEP 0 (PRE-REGISTRATION): Patient must have pathologically confirmed non-squamous non-small cell lung carcinoma (NSCLC)
- ELIGIBILITY CRITERIA FOR STEP 0 (PRE-REGISTRATION): Patient must have stage IV disease (includes M1a, M1b, or recurrent earlier stage disease), according to the 8th edition of the lung cancer Tumor Node Metastasis (TNM) classification system
- ELIGIBILITY CRITERIA FOR STEP 0 (PRE-REGISTRATION): Patient must have predominant non-squamous histology (patients with NSCLC no otherwise specified [NOS] are eligible). Mixed tumors will be categorized by the predominant cell type. If small cell elements are present the patient is ineligible
- ELIGIBILITY CRITERIA FOR STEP 0 (PRE-REGISTRATION): Patient's tumor(s) must be tested and known negative for EGFR tyrosinase kinase inhibitor (TKI) sensitizing mutations (EGFR Exon 19 deletions, L858R, L861Q, G719X) and ALK gene rearrangements (by fluorescence in situ hybridization [FISH], next generation sequencing [NGS], or immunohistochemistry [IHC]) by routine Clinical Laboratory Improvement Act (CLIA)-certified clinical testing methods. Negative circulating tumor deoxyribonucleic acid (DNA) results alone are not acceptable. Prior testing for tumor PD-L1 status is not required
-
ELIGIBILITY CRITERIA FOR STEP 0 (PRE-REGISTRATION): Patients WITHOUT tumors with known molecular alterations in ROS1, MET, RET, or must have progressed radiographically (per local investigator assessment) following one, but only one, line of platinum-based chemotherapy AND one, but only one, line of prior immunotherapy. Lines of therapy are defined by clinical or radiographic progression. Patients may have received chemotherapy and immunotherapy either concurrently or sequentially in either order. Patient must have received at least 2 prior doses of checkpoint inhibitor therapy in an every 2, 3, or 4 week schedule. No submission of molecular testing is required and patients may be registered for Step 0 then proceed directly to Step 1 screening OR Patients with tumors with known molecular alterations in ROS1, MET, and RET must have progressed radiographically (per local investigator clinical assessment) on at least one line of prior chemotherapy or targeted therapy, but there is no limit on number of prior number. Reciept of prior immunotherapy is allowed but not required.
- Known molecular alterations in ROS1 , MET, and RET are defined as below ROS1 gene rearrangement by FISH or DNA analysis. In addition to above requirements, these patients must have progressed on at least one prior ROS1 TKI therapy
- MET exon 14 splice mutations on DNA analysis. In addition to above requirements, prior MET directed TKI therapy is optional
- MET mutations predicted to be sensitive to MET inhibitor. In addition to above requirements, prior MET directed TKI therapy is optional
- High MET amplification by FISH (characterized by a fluorescence in situ hybridization MET/CEP7 ratio of 5 or greater); OR MET amplification by DNA NGS CLIA certified assay. In addition to above requirements, prior MET directed TKI therapy is optional
-
RET gene rearrangement by FISH or DNA analysis. In addition to above requirements, prior RET directed TKI therapy is optional
- During Step 0 screening, CLIA reports of the testing results must be submitted via Medidata Rave for central review for instructions. The central review will be performed by the study chair, co-chair, biology co-chair, and/or a delegate to determine that the results indicate a patient's eligibility for targeted therapy. CLIA reports that contain information pertaining to any of the above mutations will be uploaded to Medidata Rave for central review of documentation for determination of patient eligibility for targeted therapy (Arm T). Central testing of tissue will not be performed. Institutions will be notified of the patient's eligibility status for Arm T within two (2) business days of submission of the molecular testing reports. Patients with tumors with the above known molecular alterations are eligible for cohort Arm Z following Step 1 eligibility review. Patients without tumors with the above known molecular alterations for randomization to Arm A, B or C following Step 1 eligibility review
- ELIGIBILITY CRITERIA FOR STEP 0 (PRE-REGISTRATION): NOTE: Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen (in the opinion of the treating physician) are eligible for this trial
- ELIGIBILITY CRITERIA FOR STEP 0 (PRE-REGISTRATION): Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents (such as anthracycline or human epidermal growth factor receptor (HER2)-directed antibody therapy, but not prior checkpoint inhibitor therapy), must have a clinical risk assessment of cardiac function using the New York Heart Association functional classification. To be eligible for this trial, patients must be class 2B or better
- ELIGIBILITY CRITERIA FOR STEP 0 (PRE-REGISTRATION): Patient must have Eastern Cooperative Oncology Group (ECOG) performance status 0-1
- ELIGIBILITY CRITERIA FOR STEP 1 (RANDOMIZATION/REGISTRATION) FOR ALL TREATMENT ARMS: Patient must have met the eligibility criteria outlined above
- ELIGIBILITY CRITERIA FOR STEP 1 (RANDOMIZATION/REGISTRATION) FOR ALL TREATMENT ARMS: Patient must have measurable disease as defined by RECIST version (v) 1.1 criteria. Measurements must be obtained within 4 weeks prior to randomization/registration
- ELIGIBILITY CRITERIA FOR STEP 1 (RANDOMIZATION/REGISTRATION) FOR ALL TREATMENT ARMS: Patient must have an anticipated life expectancy greater than 3 months
-
ELIGIBILITY CRITERIA FOR STEP 1 (RANDOMIZATION/REGISTRATION) FOR ALL TREATMENT ARMS: Any prior chemotherapy (based on administration schedule) must have been completed in greater than or equal to the following times prior to randomization/registration:
- Chemotherapy/targeted oral therapy administered in a daily or weekly schedule must be completed >= 1 week prior to randomization/registration
- Any chemotherapy administered in an every 2 week or greater schedule must be completed >= 2 weeks prior to randomization/registration
- Additionally, patient should be recovered to equal to or less than grade 1 toxicities related to any prior treatment, unless adverse events (AE[s]) are clinically non significant and/or stable on supportive therapy (as determined by the treating physician)
- ELIGIBILITY CRITERIA FOR STEP 1 (RANDOMIZATION/REGISTRATION) FOR ALL TREATMENT ARMS: Leukocytes >= 3,000/mcL (obtained within 2 weeks prior to randomization/registration)
- ELIGIBILITY CRITERIA FOR STEP 1 (RANDOMIZATION/REGISTRATION) FOR ALL TREATMENT ARMS: Absolute neutrophil count >= 1,500/mcL (obtained within 2 weeks prior to randomization/registration)
- ELIGIBILITY CRITERIA FOR STEP 1 (RANDOMIZATION/REGISTRATION) FOR ALL TREATMENT ARMS: Platelets >= 100,000/mcL (obtained within 2 weeks prior to randomization/registration)
- ELIGIBILITY CRITERIA FOR STEP 1 (RANDOMIZATION/REGISTRATION) FOR ALL TREATMENT ARMS: Hemoglobin >= 9 g/dL (obtained within 2 weeks prior to randomization/registration)
- ELIGIBILITY CRITERIA FOR STEP 1 (RANDOMIZATION/REGISTRATION) FOR ALL TREATMENT ARMS: Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) (obtained within 2 weeks prior to randomization/registration)
- ELIGIBILITY CRITERIA FOR STEP 1 (RANDOMIZATION/REGISTRATION) FOR ALL TREATMENT ARMS: Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) and alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< 2.5 x ULN (obtained within 2 weeks prior to randomization/registration)
- ELIGIBILITY CRITERIA FOR STEP 1 (RANDOMIZATION/REGISTRATION) FOR ALL TREATMENT ARMS: Creatinine =< 1.5 x ULN OR calculated (Cockcroft-Gault formula) or measured creatinine clearance >= 50 mL/min/1.73 m^2 (normalized to body surface area [BSA]) for patients with creatinine levels greater than 1.5 times the institutional normal creatinine =< 1.5 x ULN or creatinine clearance >= 50 ml/min/1.73 m^2 (obtained within 2 weeks prior to randomization/registration)
- ELIGIBILITY CRITERIA FOR STEP 1 (RANDOMIZATION/REGISTRATION) FOR ALL TREATMENT ARMS: Patient must have corrected QT interval calculated by the Fridericia formula QTc corrected by Fridericia (QTcF) =< 500 ms within 28 days prior to randomization/registration
- ELIGIBILITY CRITERIA FOR STEP 1 (RANDOMIZATION/REGISTRATION) FOR ALL TREATMENT ARMS: Patient must be able to swallow tablets
- ELIGIBILITY CRITERIA FOR STEP 1 (RANDOMIZATION/REGISTRATION) FOR ALL TREATMENT ARMS: Patients with treated brain metastases are eligible if follow-up brain imaging after central nervous system (CNS)-directed therapy shows no evidence of progression
-
ELIGIBILITY CRITERIA FOR STEP 1 (RANDOMIZATION/REGISTRATION) FOR ALL TREATMENT ARMS: Patients with new or progressive brain metastases (active brain metastases) are eligible if the treating physician determines that immediate CNS specific treatment is not required and is unlikely to be required during the first cycle of study treatment.
- Patient must meet one of the following criteria with respect to brain metastases: Patients with no known brain metastasis must have baseline brain imaging within 12 weeks prior to study randomization/registration not demonstrating brain metastases OR patients with known brain metastases must have baseline brain imaging and completed treatment to all symptomatic brain metastases (with whole brain radiation or radiosurgery; or complete neurosurgical resection >= 3 months prior to randomization/registration) >= 4 weeks prior to randomization/registration. They must be clinically stable. Known leptomeningeal disease is not allowed
- ELIGIBILITY CRITERIA FOR STEP 1 (RANDOMIZATION/REGISTRATION) FOR ALL TREATMENT ARMS: Known human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months of registration are eligible for this trial
- ELIGIBILITY CRITERIA FOR STEP 1 (RANDOMIZATION/REGISTRATION) FOR ALL TREATMENT ARMS: For patients with known history of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy at time of registration/randomization, if indicated
- ELIGIBILITY CRITERIA FOR STEP 1 (RANDOMIZATION/REGISTRATION) FOR ALL TREATMENT ARMS: Patients with a known history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load at time of registration/randomization
- ADDITIONAL ELIGIBILITY CRITERIA FOR STEP 1 (REGISTRATION) TARGETED ARM T: Patient was registered to step 0, targeted arm and central review results report the patient is eligible for arm T
- ADDITIONAL ELIGIBILITY CRITERIA FOR STEP 1 (REGISTRATION) TARGETED ARM T: Patients with ROS1 gene rearrangements must have progressed on at least one prior ROS1 targeted therapy such as crizotinib
-
ADDITIONAL ELIGIBILITY CRITERIA FOR STEP 1 (REGISTRATION) TARGETED ARM T: Patient must have progressed radiographically (per local investigator clinical assessment) on at least one line of prior chemotherapy or targeted therapy, but there is no limit on number of prior number. Prior immunotherapy is allowed but not required. Prior bevacizumab with chemo is allowed.
- NOTE: The requirement for prior chemotherapy will be met if patients have recurrence within 6 months after prior adjuvant platinum based chemotherapy for early stage disease, or recurrence within 6 months after prior radiotherapy plus platinum based chemotherapy for locally advanced disease
- NOTE: Patients with unresectable stage III NSCLC who have received chemo and radiation then consolidation durvalumab, followed by progression are eligible if progression happens after > 2 doses of durvalumab. Prior bevacizumab with chemo is also allowed
- STEP 2 ELIGIBILITY CRITERIA (CROSSOVER ARM Z): Patients must have met all eligibility requirements for Step 1 at time of registration to Step 1 to be eligible for Step 2
- STEP 2 ELIGIBILITY CRITERIA (CROSSOVER ARM Z): Patients must have radiographic progressive disease per RECIST criteria after >= 2 cycles of therapy on arm C
- STEP 2 ELIGIBILITY CRITERIA (CROSSOVER ARM Z): Patients must be registered to step 2 within 4 weeks of the last dose of treatment administration from step 1
- STEP 2 ELIGIBILITY CRITERIA (CROSSOVER ARM Z): Patients must have an ECOG performance status between 0-2
- STEP 2 ELIGIBILITY CRITERIA (CROSSOVER ARM Z): Patients must have recovered to baseline (pre-step 1) or Common Terminology Criteria for Adverse Events (CTCAE) v.5.0 =< grade 1 from toxicity due to all prior therapies except alopecia and other non-clinically significant adverse events (AEs)
- STEP 2 ELIGIBILITY CRITERIA (CROSSOVER ARM Z): Leukocytes >= 3,000/mcL (obtained within 2 weeks prior to randomization/registration)
- STEP 2 ELIGIBILITY CRITERIA (CROSSOVER ARM Z): Absolute neutrophil count >= 1,500/mcL (obtained within 2 weeks prior to randomization/registration)
- STEP 2 ELIGIBILITY CRITERIA (CROSSOVER ARM Z): Platelets >= 100,000/mcL (obtained within 2 weeks prior to randomization/registration)
- STEP 2 ELIGIBILITY CRITERIA (CROSSOVER ARM Z): Hemoglobin >= 9 g/dL (obtained within 2 weeks prior to randomization/registration)
- Total bilirubin =< 1.5 x institutional ULN (obtained within 2 weeks prior to randomization/registration)
- STEP 2 ELIGIBILITY CRITERIA (CROSSOVER ARM Z): Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) and alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< 2.5 x ULN (obtained within 2 weeks prior to randomization/registration)
- STEP 2 ELIGIBILITY CRITERIA (CROSSOVER ARM Z): Creatinine =< 1.5 x ULN OR calculated (Cockcroft-Gault formula) or measured creatinine clearance >= 50 mL/min/1.73 m^2 (normalized to BSA) for patients with creatinine levels greater than 1.5 times the institutional normal creatinine =< 1.5 x ULN or creatinine clearance >= 50 ml/min/1.73 m^2 (obtained within 2 weeks prior to randomization/registration)
- STEP 2 ELIGIBILITY CRITERIA (CROSSOVER ARM Z): Patients must have corrected QT interval calculated by the Fridericia formula (QTcF) =< 500 ms within 28 days before registration
Exclusion Criteria:
- ELIGIBILITY CRITERIA FOR STEP 1 (RANDOMIZATION/REGISTRATION) FOR ALL TREATMENT ARMS: Patient must not have had any prior radiation therapy for bone metastasis within 2 weeks, or any other radiation therapy within 4 weeks prior to randomization/registration
- ELIGIBILITY CRITERIA FOR STEP

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04310007


United States, Alaska | |
Anchorage Associates in Radiation Medicine | Recruiting |
Anchorage, Alaska, United States, 98508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Anchorage Radiation Therapy Center | Recruiting |
Anchorage, Alaska, United States, 99504 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Alaska Breast Care and Surgery LLC | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Alaska Oncology and Hematology LLC | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Alaska Women's Cancer Care | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Anchorage Oncology Centre | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Katmai Oncology Group | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Alaska Medical Center | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Fairbanks Memorial Hospital | Recruiting |
Fairbanks, Alaska, United States, 99701 | |
Contact: Site Public Contact 907-458-3043 Veronica.Stevenson@foundationhealth.org | |
Principal Investigator: Nicholas DiBella | |
United States, Arizona | |
Kingman Regional Medical Center | Recruiting |
Kingman, Arizona, United States, 86401 | |
Contact: Site Public Contact ecog.rss@jimmy.harvard.edu | |
Principal Investigator: John A. Ellerton | |
Cancer Center at Saint Joseph's | Recruiting |
Phoenix, Arizona, United States, 85004 | |
Contact: Site Public Contact 602-406-8222 | |
Principal Investigator: Richard L. Deming | |
United States, Arkansas | |
Mercy Hospital Fort Smith | Recruiting |
Fort Smith, Arkansas, United States, 72903 | |
Contact: Site Public Contact 800-378-9373 | |
Principal Investigator: Jay W. Carlson | |
CHI Saint Vincent Cancer Center Hot Springs | Recruiting |
Hot Springs, Arkansas, United States, 71913 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, California | |
Mission Hope Medical Oncology - Arroyo Grande | Recruiting |
Arroyo Grande, California, United States, 93420 | |
Contact: Site Public Contact 916-851-2283 research@dignityhealth.org | |
Principal Investigator: Richard L. Deming | |
PCR Oncology | Recruiting |
Arroyo Grande, California, United States, 93420 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Providence Saint Joseph Medical Center/Disney Family Cancer Center | Recruiting |
Burbank, California, United States, 91505 | |
Contact: Site Public Contact 818-847-4793 Najee.Boucher@providence.org | |
Principal Investigator: Alison K. Conlin | |
Washington Hospital | Recruiting |
Fremont, California, United States, 94538 | |
Contact: Site Public Contact 510-745-6433 | |
Principal Investigator: Bogdan S. Eftimie | |
Stanford Cancer Institute Palo Alto | Recruiting |
Palo Alto, California, United States, 94304 | |
Contact: Site Public Contact 650-498-7061 ccto-office@stanford.edu | |
Principal Investigator: Joel W. Neal | |
Pacific Central Coast Health Center-San Luis Obispo | Recruiting |
San Luis Obispo, California, United States, 93401 | |
Contact: Site Public Contact Diane.DeVos-Schmidt@DignityHealth.org | |
Principal Investigator: Richard L. Deming | |
Mission Hope Medical Oncology - Santa Maria | Recruiting |
Santa Maria, California, United States, 93444 | |
Contact: Site Public Contact 916-851-2283 research@dignityhealth.org | |
Principal Investigator: Richard L. Deming | |
United States, Colorado | |
Rocky Mountain Cancer Centers-Aurora | Recruiting |
Aurora, Colorado, United States, 80012 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
The Medical Center of Aurora | Recruiting |
Aurora, Colorado, United States, 80012 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Boulder Community Foothills Hospital | Recruiting |
Boulder, Colorado, United States, 80303 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Rocky Mountain Cancer Centers-Boulder | Recruiting |
Boulder, Colorado, United States, 80304 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Rocky Mountain Cancer Centers - Centennial | Recruiting |
Centennial, Colorado, United States, 80112 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Penrose-Saint Francis Healthcare | Recruiting |
Colorado Springs, Colorado, United States, 80907 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Rocky Mountain Cancer Centers-Penrose | Recruiting |
Colorado Springs, Colorado, United States, 80907 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Richard L. Deming | |
Cancer Center of Colorado at Sloan's Lake | Suspended |
Denver, Colorado, United States, 80204 | |
National Jewish Health-Main Campus | Suspended |
Denver, Colorado, United States, 80206 | |
The Women's Imaging Center | Recruiting |
Denver, Colorado, United States, 80209 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Porter Adventist Hospital | Recruiting |
Denver, Colorado, United States, 80210 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Colorado Blood Cancer Institute | Recruiting |
Denver, Colorado, United States, 80218 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Presbyterian - Saint Lukes Medical Center - Health One | Recruiting |
Denver, Colorado, United States, 80218 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Rocky Mountain Cancer Centers-Midtown | Recruiting |
Denver, Colorado, United States, 80218 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
SCL Health Saint Joseph Hospital | Suspended |
Denver, Colorado, United States, 80218 | |
Rocky Mountain Cancer Centers-Rose | Recruiting |
Denver, Colorado, United States, 80220 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Western Surgical Care | Recruiting |
Denver, Colorado, United States, 80220 | |
Contact: Site Public Contact 303-777-2663 | |
Principal Investigator: Nicholas DiBella | |
Mercy Medical Center | Recruiting |
Durango, Colorado, United States, 81301 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Southwest Oncology PC | Recruiting |
Durango, Colorado, United States, 81301 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Mountain Blue Cancer Care Center - Swedish | Recruiting |
Englewood, Colorado, United States, 80113 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Swedish Medical Center | Recruiting |
Englewood, Colorado, United States, 80113 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Poudre Valley Hospital | Recruiting |
Fort Collins, Colorado, United States, 80524 | |
Contact: Site Public Contact 970-297-6150 | |
Principal Investigator: William T. Purcell | |
Cancer Care and Hematology-Fort Collins | Recruiting |
Fort Collins, Colorado, United States, 80528 | |
Contact: Site Public Contact ecog.rss@jimmy.harvard.edu | |
Principal Investigator: William T. Purcell | |
National Jewish Health-Western Hematology Oncology | Suspended |
Golden, Colorado, United States, 80401 | |
Saint Mary's Hospital and Regional Medical Center | Suspended |
Grand Junction, Colorado, United States, 81501 | |
North Colorado Medical Center | Recruiting |
Greeley, Colorado, United States, 80631 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
UCHealth Greeley Hospital | Recruiting |
Greeley, Colorado, United States, 80631 | |
Contact: Site Public Contact ecog.rss@jimmy.harvard.edu | |
Principal Investigator: William T. Purcell | |
UCHealth Highlands Ranch Hospital | Recruiting |
Highlands Ranch, Colorado, United States, 80129 | |
Contact: Site Public Contact 720-848-0650 | |
Principal Investigator: William T. Purcell | |
Good Samaritan Medical Center | Suspended |
Lafayette, Colorado, United States, 80026 | |
Saint Anthony Hospital | Recruiting |
Lakewood, Colorado, United States, 80228 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Rocky Mountain Cancer Centers-Littleton | Recruiting |
Littleton, Colorado, United States, 80120 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Littleton Adventist Hospital | Recruiting |
Littleton, Colorado, United States, 80122 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Rocky Mountain Cancer Centers-Sky Ridge | Recruiting |
Lone Tree, Colorado, United States, 80124 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Sky Ridge Medical Center | Recruiting |
Lone Tree, Colorado, United States, 80124 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Longmont United Hospital | Recruiting |
Longmont, Colorado, United States, 80501 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Rocky Mountain Cancer Centers-Longmont | Recruiting |
Longmont, Colorado, United States, 80501 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Richard L. Deming | |
Medical Center of the Rockies | Recruiting |
Loveland, Colorado, United States, 80538 | |
Contact: Site Public Contact 970-203-7083 | |
Principal Investigator: William T. Purcell | |
McKee Medical Center | Recruiting |
Loveland, Colorado, United States, 80539 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Parker Adventist Hospital | Recruiting |
Parker, Colorado, United States, 80138 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Mary Corwin Medical Center | Recruiting |
Pueblo, Colorado, United States, 81004 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
National Jewish Health-Northern Hematology Oncology | Suspended |
Thornton, Colorado, United States, 80260 | |
United States, Connecticut | |
Veterans Affairs Connecticut Healthcare System-West Haven Campus | Recruiting |
West Haven, Connecticut, United States, 06516 | |
Contact: Site Public Contact 203-937-3421 ext 2832 | |
Principal Investigator: Herta H. Chao | |
United States, Florida | |
Holy Cross Hospital | Recruiting |
Fort Lauderdale, Florida, United States, 33308 | |
Contact: Site Public Contact 954-267-7750 | |
Principal Investigator: Philip J. Stella | |
United States, Georgia | |
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler | Recruiting |
Savannah, Georgia, United States, 31405 | |
Contact: Site Public Contact 912-819-5704 underberga@sjchs.org | |
Principal Investigator: Howard A. Zaren | |
United States, Idaho | |
Saint Alphonsus Cancer Care Center-Boise | Recruiting |
Boise, Idaho, United States, 83706 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Boise | Recruiting |
Boise, Idaho, United States, 83712 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Saint Alphonsus Cancer Care Center-Caldwell | Recruiting |
Caldwell, Idaho, United States, 83605 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Kootenai Medical Center | Recruiting |
Coeur d'Alene, Idaho, United States, 83814 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Walter Knox Memorial Hospital | Recruiting |
Emmett, Idaho, United States, 83617 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Fruitland | Recruiting |
Fruitland, Idaho, United States, 83619 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Idaho Urologic Institute-Meridian | Recruiting |
Meridian, Idaho, United States, 83642 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Meridian | Recruiting |
Meridian, Idaho, United States, 83642 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Saint Alphonsus Medical Center-Nampa | Recruiting |
Nampa, Idaho, United States, 83686 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Nampa | Recruiting |
Nampa, Idaho, United States, 83686 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Kootenai Cancer Center | Recruiting |
Post Falls, Idaho, United States, 83854 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Kootenai Cancer Clinic | Recruiting |
Sandpoint, Idaho, United States, 83864 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Twin Falls | Recruiting |
Twin Falls, Idaho, United States, 83301 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
United States, Illinois | |
Rush - Copley Medical Center | Recruiting |
Aurora, Illinois, United States, 60504 | |
Contact: Site Public Contact 630-978-6212 Cancer.Research@rushcopley.com | |
Principal Investigator: Priyank P. Patel | |
Illinois CancerCare-Bloomington | Recruiting |
Bloomington, Illinois, United States, 61704 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Canton | Recruiting |
Canton, Illinois, United States, 61520 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Memorial Hospital of Carbondale | Recruiting |
Carbondale, Illinois, United States, 62902 | |
Contact: Site Public Contact 618-457-5200 clinical.research@sih.net | |
Principal Investigator: Bryan A. Faller | |
SIH Cancer Institute | Recruiting |
Carterville, Illinois, United States, 62918 | |
Contact: Site Public Contact 618-985-3333 clinical.research@sih.net | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Carthage | Recruiting |
Carthage, Illinois, United States, 62321 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Centralia Oncology Clinic | Recruiting |
Centralia, Illinois, United States, 62801 | |
Contact: Site Public Contact 217-876-4740 rhamrick@dmhhs.org | |
Principal Investigator: Bryan A. Faller | |
Carle on Vermilion | Recruiting |
Danville, Illinois, United States, 61832 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Priyank P. Patel | |
Cancer Care Specialists of Illinois - Decatur | Recruiting |
Decatur, Illinois, United States, 62526 | |
Contact: Site Public Contact 217-876-4740 rhamrick@dmhhs.org | |
Principal Investigator: Bryan A. Faller | |
Decatur Memorial Hospital | Recruiting |
Decatur, Illinois, United States, 62526 | |
Contact: Site Public Contact 217-876-4740 rhamrick@dmhhs.org | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Dixon | Recruiting |
Dixon, Illinois, United States, 61021 | |
Contact: Site Public Contact 815-285-7800 | |
Principal Investigator: Bryan A. Faller | |
Carle Physician Group-Effingham | Recruiting |
Effingham, Illinois, United States, 62401 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Priyank P. Patel | |
Crossroads Cancer Center | Recruiting |
Effingham, Illinois, United States, 62401 | |
Contact: Site Public Contact 217-876-4740 rhamrick@dmhhs.org | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Eureka | Recruiting |
Eureka, Illinois, United States, 61530 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Galesburg | Recruiting |
Galesburg, Illinois, United States, 61401 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Western Illinois Cancer Treatment Center | Recruiting |
Galesburg, Illinois, United States, 61401 | |
Contact: Site Public Contact 309-344-2831 | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Kewanee Clinic | Recruiting |
Kewanee, Illinois, United States, 61443 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Macomb | Recruiting |
Macomb, Illinois, United States, 61455 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Carle Physician Group-Mattoon/Charleston | Recruiting |
Mattoon, Illinois, United States, 61938 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Priyank P. Patel | |
Good Samaritan Regional Health Center | Recruiting |
Mount Vernon, Illinois, United States, 62864 | |
Contact: Site Public Contact 618-242-4600 | |
Principal Investigator: Jay W. Carlson | |
Cancer Care Center of O'Fallon | Recruiting |
O'Fallon, Illinois, United States, 62269 | |
Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Ottawa Clinic | Recruiting |
Ottawa, Illinois, United States, 61350 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Pekin | Recruiting |
Pekin, Illinois, United States, 61554 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Peoria | Recruiting |
Peoria, Illinois, United States, 61615 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Methodist Medical Center of Illinois | Recruiting |
Peoria, Illinois, United States, 61636 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Peru | Recruiting |
Peru, Illinois, United States, 61354 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Valley Radiation Oncology | Recruiting |
Peru, Illinois, United States, 61354 | |
Contact: Site Public Contact 815-664-4141 | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Princeton | Recruiting |
Princeton, Illinois, United States, 61356 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Southern Illinois University School of Medicine | Recruiting |
Springfield, Illinois, United States, 62702 | |
Contact: Site Public Contact 217-545-7929 | |
Principal Investigator: Bryan A. Faller | |
Springfield Clinic | Recruiting |
Springfield, Illinois, United States, 62702 | |
Contact: Site Public Contact 800-444-7541 | |
Principal Investigator: Bryan A. Faller | |
Memorial Medical Center | Recruiting |
Springfield, Illinois, United States, 62781 | |
Contact: Site Public Contact 217-788-3528 | |
Principal Investigator: Bryan A. Faller | |
Southwest Illinois Health Services LLP | Suspended |
Swansea, Illinois, United States, 62226 | |
Carle Cancer Center | Recruiting |
Urbana, Illinois, United States, 61801 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Priyank P. Patel | |
The Carle Foundation Hospital | Recruiting |
Urbana, Illinois, United States, 61801 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Priyank P. Patel | |
Rush-Copley Healthcare Center | Recruiting |
Yorkville, Illinois, United States, 60560 | |
Contact: Site Public Contact 630-978-6212 Cancer.Research@rushcopley.com | |
Principal Investigator: Priyank P. Patel | |
United States, Indiana | |
Reid Health | Recruiting |
Richmond, Indiana, United States, 47374 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Memorial Hospital of South Bend | Recruiting |
South Bend, Indiana, United States, 46601 | |
Contact: Site Public Contact 800-284-7370 | |
Principal Investigator: Nibal Saad | |
United States, Iowa | |
Mary Greeley Medical Center | Recruiting |
Ames, Iowa, United States, 50010 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
McFarland Clinic PC - Ames | Recruiting |
Ames, Iowa, United States, 50010 | |
Contact: Site Public Contact 515-239-4734 ksoder@mcfarlandclinic.com | |
Principal Investigator: Debra M. Prow | |
University of Iowa Healthcare Cancer Services Quad Cities | Recruiting |
Bettendorf, Iowa, United States, 52722 | |
Contact: Site Public Contact 563-355-7733 kedaprile@rccqc.com | |
Principal Investigator: Muhammad Furqan | |
McFarland Clinic PC-Boone | Recruiting |
Boone, Iowa, United States, 50036 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
Medical Oncology and Hematology Associates-West Des Moines | Recruiting |
Clive, Iowa, United States, 50325 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Mercy Cancer Center-West Lakes | Recruiting |
Clive, Iowa, United States, 50325 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Alegent Health Mercy Hospital | Recruiting |
Council Bluffs, Iowa, United States, 51503 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Greater Regional Medical Center | Recruiting |
Creston, Iowa, United States, 50801 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Iowa Methodist Medical Center | Recruiting |
Des Moines, Iowa, United States, 50309 | |
Contact: Site Public Contact 515-241-6727 | |
Principal Investigator: Robert J. Behrens | |
Medical Oncology and Hematology Associates-Des Moines | Recruiting |
Des Moines, Iowa, United States, 50309 | |
Contact: Site Public Contact 515-282-2921 | |
Principal Investigator: Robert J. Behrens | |
Broadlawns Medical Center | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 515-282-2200 | |
Principal Investigator: Robert J. Behrens | |
Medical Oncology and Hematology Associates-Laurel | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Mercy Medical Center - Des Moines | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Iowa Lutheran Hospital | Recruiting |
Des Moines, Iowa, United States, 50316 | |
Contact: Site Public Contact 515-241-8704 | |
Principal Investigator: Robert J. Behrens | |
McFarland Clinic PC-Trinity Cancer Center | Recruiting |
Fort Dodge, Iowa, United States, 50501 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
Trinity Regional Medical Center | Recruiting |
Fort Dodge, Iowa, United States, 50501 | |
Contact: Site Public Contact 515-574-8302 | |
Principal Investigator: Robert J. Behrens | |
University of Iowa/Holden Comprehensive Cancer Center | Recruiting |
Iowa City, Iowa, United States, 52242 | |
Contact: Site Public Contact 800-237-1225 | |
Principal Investigator: Muhammad Furqan | |
McFarland Clinic PC-Jefferson | Recruiting |
Jefferson, Iowa, United States, 50129 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
McFarland Clinic PC-Marshalltown | Recruiting |
Marshalltown, Iowa, United States, 50158 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
Methodist West Hospital | Recruiting |
West Des Moines, Iowa, United States, 50266-7700 | |
Contact: Site Public Contact 515-343-1000 | |
Principal Investigator: Robert J. Behrens | |
Mercy Medical Center-West Lakes | Recruiting |
West Des Moines, Iowa, United States, 50266 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, Kentucky | |
Flaget Memorial Hospital | Recruiting |
Bardstown, Kentucky, United States, 40004 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Commonwealth Cancer Center-Corbin | Recruiting |
Corbin, Kentucky, United States, 40701 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Joseph Radiation Oncology Resource Center | Recruiting |
Lexington, Kentucky, United States, 40504 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Joseph Hospital East | Recruiting |
Lexington, Kentucky, United States, 40509 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Joseph London | Recruiting |
London, Kentucky, United States, 40741 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Jewish Hospital | Recruiting |
Louisville, Kentucky, United States, 40202 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saints Mary and Elizabeth Hospital | Recruiting |
Louisville, Kentucky, United States, 40215 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Jewish Hospital Medical Center Northeast | Recruiting |
Louisville, Kentucky, United States, 40245 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Jewish Hospital Medical Center South | Recruiting |
Shepherdsville, Kentucky, United States, 40165 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, Louisiana | |
LSU Health Baton Rouge-North Clinic | Recruiting |
Baton Rouge, Louisiana, United States, 70805 | |
Contact: Site Public Contact 225-215-1353 clinicalresearch@marybird.com | |
Principal Investigator: David S. Hanson | |
Louisiana Hematology Oncology Associates LLC | Recruiting |
Baton Rouge, Louisiana, United States, 70809 | |
Contact: Site Public Contact 225-215-1353 clinicalresearch@marybird.com | |
Principal Investigator: David S. Hanson | |
Mary Bird Perkins Cancer Center | Recruiting |
Baton Rouge, Louisiana, United States, 70809 | |
Contact: Site Public Contact 225-215-1353 clinicalresearch@marybird.com | |
Principal Investigator: David S. Hanson | |
Our Lady of the Lake Physicians Group - Medical Oncology | Recruiting |
Baton Rouge, Louisiana, United States, 70809 | |
Contact: Site Public Contact 225-215-1353 clinicalresearch@marybird.com | |
Principal Investigator: David S. Hanson | |
Northshore Oncology Associates-Covington | Recruiting |
Covington, Louisiana, United States, 70433 | |
Contact: Site Public Contact 225-215-1353 clinicalresearch@marybird.com | |
Principal Investigator: David S. Hanson | |
Terrebonne General Medical Center | Recruiting |
Houma, Louisiana, United States, 70360 | |
Contact: Site Public Contact 985-850-6300 ann.hooks@tgmc.com | |
Principal Investigator: David S. Hanson | |
United States, Massachusetts | |
Boston Medical Center | Recruiting |
Boston, Massachusetts, United States, 02118 | |
Contact: Site Public Contact 617-638-8265 | |
Principal Investigator: Umit Tapan | |
UMass Memorial Medical Center - University Campus | Recruiting |
Worcester, Massachusetts, United States, 01655 | |
Contact: Site Public Contact 508-856-3216 cancer.research@umassmed.edu | |
Principal Investigator: William V. Walsh | |
United States, Michigan | |
Hickman Cancer Center | Recruiting |
Adrian, Michigan, United States, 49221 | |
Contact: Site Public Contact 517-265-0116 | |
Principal Investigator: Rex B. Mowat | |
Saint Joseph Mercy Hospital | Recruiting |
Ann Arbor, Michigan, United States, 48106 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Bronson Battle Creek | Recruiting |
Battle Creek, Michigan, United States, 49017 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
IHA Hematology Oncology Consultants-Brighton | Recruiting |
Brighton, Michigan, United States, 48114 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Saint Joseph Mercy Brighton | Recruiting |
Brighton, Michigan, United States, 48114 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
IHA Hematology Oncology Consultants-Canton | Recruiting |
Canton, Michigan, United States, 48188 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Saint Joseph Mercy Canton | Recruiting |
Canton, Michigan, United States, 48188 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Caro Cancer Center | Recruiting |
Caro, Michigan, United States, 48723 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
IHA Hematology Oncology Consultants-Chelsea | Recruiting |
Chelsea, Michigan, United States, 48118 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Saint Joseph Mercy Chelsea | Recruiting |
Chelsea, Michigan, United States, 48118 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Hematology Oncology Consultants-Clarkston | Recruiting |
Clarkston, Michigan, United States, 48346 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Newland Medical Associates-Clarkston | Recruiting |
Clarkston, Michigan, United States, 48346 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Ascension Saint John Hospital | Recruiting |
Detroit, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Great Lakes Cancer Management Specialists-Doctors Park | Recruiting |
East China Township, Michigan, United States, 48054 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Genesee Cancer and Blood Disease Treatment Center | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Genesee Hematology Oncology PC | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Genesys Hurley Cancer Institute | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Hurley Medical Center | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Helen DeVos Children's Hospital at Spectrum Health | Recruiting |
Grand Rapids, Michigan, United States, 49503 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Mercy Health Saint Mary's | Recruiting |
Grand Rapids, Michigan, United States, 49503 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Spectrum Health at Butterworth Campus | Recruiting |
Grand Rapids, Michigan, United States, 49503 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Academic Hematology Oncology Specialists | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Michigan Breast Specialists-Grosse Pointe Woods | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Bronson Methodist Hospital | Recruiting |
Kalamazoo, Michigan, United States, 49007 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
West Michigan Cancer Center | Recruiting |
Kalamazoo, Michigan, United States, 49007 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Borgess Medical Center | Recruiting |
Kalamazoo, Michigan, United States, 49048 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Sparrow Hospital | Recruiting |
Lansing, Michigan, United States, 48912 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Hope Cancer Clinic | Recruiting |
Livonia, Michigan, United States, 48154 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Saint Mary Mercy Hospital | Recruiting |
Livonia, Michigan, United States, 48154 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Great Lakes Cancer Management Specialists-Macomb Medical Campus | Recruiting |
Macomb, Michigan, United States, 48044 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Michigan Breast Specialists-Macomb Township | Recruiting |
Macomb, Michigan, United States, 48044 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Saint Mary's Oncology/Hematology Associates of Marlette | Recruiting |
Marlette, Michigan, United States, 48453 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Toledo Clinic Cancer Centers-Monroe | Recruiting |
Monroe, Michigan, United States, 48162 | |
Contact: Site Public Contact 800-444-3561 | |
Principal Investigator: Rex B. Mowat | |
Mercy Health Mercy Campus | Recruiting |
Muskegon, Michigan, United States, 49444 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Lakeland Hospital Niles | Recruiting |
Niles, Michigan, United States, 49120 | |
Contact: Site Public Contact 616-391-1230 | |
Principal Investigator: Kathleen J. Yost | |
Cancer and Hematology Centers of Western Michigan - Norton Shores | Recruiting |
Norton Shores, Michigan, United States, 49444 | |
Contact: Site Public Contact 616-391-1230 connie.szczepanek@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Ascension Providence Hospitals - Novi | Recruiting |
Novi, Michigan, United States, 48374 | |
Contact: Site Public Contact 248-849-5332 karen.fife@ascension.org | |
Principal Investigator: Adam M. Forman | |
21st Century Oncology-Pontiac | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Hope Cancer Center | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Newland Medical Associates-Pontiac | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Saint Joseph Mercy Oakland | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Spectrum Health Reed City Hospital | Recruiting |
Reed City, Michigan, United States, 49677 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Great Lakes Cancer Management Specialists-Rochester Hills | Suspended |
Rochester Hills, Michigan, United States, 48309 | |
Ascension Saint Mary's Hospital | Recruiting |
Saginaw, Michigan, United States, 48601 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Oncology Hematology Associates of Saginaw Valley PC | Recruiting |
Saginaw, Michigan, United States, 48604 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Lakeland Medical Center Saint Joseph | Recruiting |
Saint Joseph, Michigan, United States, 49085 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Marie Yeager Cancer Center | Recruiting |
Saint Joseph, Michigan, United States, 49085 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Ascension Providence Hospitals - Southfield | Recruiting |
Southfield, Michigan, United States, 48075 | |
Contact: Site Public Contact 248-849-5332 karen.fife@ascension.org | |
Principal Investigator: Adam M. Forman | |
Bhadresh Nayak MD PC-Sterling Heights | Recruiting |
Sterling Heights, Michigan, United States, 48312 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Ascension Saint Joseph Hospital | Recruiting |
Tawas City, Michigan, United States, 48764 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Munson Medical Center | Recruiting |
Traverse City, Michigan, United States, 49684 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Advanced Breast Care Center PLLC | Recruiting |
Warren, Michigan, United States, 48088 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Great Lakes Cancer Management Specialists-Macomb Professional Building | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Macomb Hematology Oncology PC | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Michigan Breast Specialists-Warren | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Saint John Macomb-Oakland Hospital | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Saint Mary's Oncology/Hematology Associates of West Branch | Recruiting |
West Branch, Michigan, United States, 48661 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Metro Health Hospital | Recruiting |
Wyoming, Michigan, United States, 49519 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Huron Gastroenterology PC | Recruiting |
Ypsilanti, Michigan, United States, 48106 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
IHA Hematology Oncology Consultants-Ann Arbor | Recruiting |
Ypsilanti, Michigan, United States, 48197 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
United States, Minnesota | |
Riverwood Healthcare Center | Recruiting |
Aitkin, Minnesota, United States, 56431 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health Saint Joseph's Medical Center | Recruiting |
Brainerd, Minnesota, United States, 56401 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Fairview Ridges Hospital | Recruiting |
Burnsville, Minnesota, United States, 55337 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Minnesota Oncology - Burnsville | Recruiting |
Burnsville, Minnesota, United States, 55337 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Cambridge Medical Center | Recruiting |
Cambridge, Minnesota, United States, 55008 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Mercy Hospital | Recruiting |
Coon Rapids, Minnesota, United States, 55433 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Essentia Health - Deer River Clinic | Recruiting |
Deer River, Minnesota, United States, 56636 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health Saint Mary's - Detroit Lakes Clinic | Recruiting |
Detroit Lakes, Minnesota, United States, 56501 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health Cancer Center | Recruiting |
Duluth, Minnesota, United States, 55805 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health Saint Mary's Medical Center | Recruiting |
Duluth, Minnesota, United States, 55805 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Miller-Dwan Hospital | Recruiting |
Duluth, Minnesota, United States, 55805 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Fairview Southdale Hospital | Recruiting |
Edina, Minnesota, United States, 55435 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Lake Region Healthcare Corporation-Cancer Care | Recruiting |
Fergus Falls, Minnesota, United States, 56537 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health - Fosston | Recruiting |
Fosston, Minnesota, United States, 56542 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Unity Hospital | Recruiting |
Fridley, Minnesota, United States, 55432 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Essentia Health Hibbing Clinic | Recruiting |
Hibbing, Minnesota, United States, 55746 | |
Contact: Site Public Contact 218-786-3308 | |
Principal Investigator: Bret E. Friday | |
Fairview Clinics and Surgery Center Maple Grove | Recruiting |
Maple Grove, Minnesota, United States, 55369 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Minnesota Oncology Hematology PA-Maplewood | Recruiting |
Maplewood, Minnesota, United States, 55109 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Saint John's Hospital - Healtheast | Recruiting |
Maplewood, Minnesota, United States, 55109 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Abbott-Northwestern Hospital | Recruiting |
Minneapolis, Minnesota, United States, 55407 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Hennepin County Medical Center | Recruiting |
Minneapolis, Minnesota, United States, 55415 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Health Partners Inc | Recruiting |
Minneapolis, Minnesota, United States, 55454 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Monticello Cancer Center | Recruiting |
Monticello, Minnesota, United States, 55362 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
New Ulm Medical Center | Recruiting |
New Ulm, Minnesota, United States, 56073 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Essentia Health - Park Rapids | Recruiting |
Park Rapids, Minnesota, United States, 56470 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Fairview Northland Medical Center | Recruiting |
Princeton, Minnesota, United States, 55371 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
North Memorial Medical Health Center | Recruiting |
Robbinsdale, Minnesota, United States, 55422 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Park Nicollet Clinic - Saint Louis Park | Recruiting |
Saint Louis Park, Minnesota, United States, 55416 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Regions Hospital | Recruiting |
Saint Paul, Minnesota, United States, 55101 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
United Hospital | Recruiting |
Saint Paul, Minnesota, United States, 55102 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Essentia Health Sandstone | Recruiting |
Sandstone, Minnesota, United States, 55072 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Saint Francis Regional Medical Center | Recruiting |
Shakopee, Minnesota, United States, 55379 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Lakeview Hospital | Recruiting |
Stillwater, Minnesota, United States, 55082 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Essentia Health Virginia Clinic | Recruiting |
Virginia, Minnesota, United States, 55792 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Ridgeview Medical Center | Recruiting |
Waconia, Minnesota, United States, 55387 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Rice Memorial Hospital | Recruiting |
Willmar, Minnesota, United States, 56201 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Minnesota Oncology Hematology PA-Woodbury | Recruiting |
Woodbury, Minnesota, United States, 55125 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Fairview Lakes Medical Center | Recruiting |
Wyoming, Minnesota, United States, 55092 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
United States, Missouri | |
Saint Louis Cancer and Breast Institute-Ballwin | Recruiting |
Ballwin, Missouri, United States, 63011 | |
Contact: Site Public Contact 314-251-7058 | |
Principal Investigator: Jay W. Carlson | |
Cox Cancer Center Branson | Suspended |
Branson, Missouri, United States, 65616 | |
Saint Francis Medical Center | Recruiting |
Cape Girardeau, Missouri, United States, 63703 | |
Contact: Site Public Contact 573-334-2230 sfmc@sfmc.net | |
Principal Investigator: Bryan A. Faller | |
Southeast Cancer Center | Recruiting |
Cape Girardeau, Missouri, United States, 63703 | |
Contact: Site Public Contact 573-651-5550 | |
Principal Investigator: Bryan A. Faller | |
Parkland Health Center - Farmington | Recruiting |
Farmington, Missouri, United States, 63640 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Capital Region Southwest Campus | Recruiting |
Jefferson City, Missouri, United States, 65109 | |
Contact: Site Public Contact 573-632-4814 swooden@mail.crmc.org | |
Principal Investigator: Bryan A. Faller | |
Freeman Health System | Recruiting |
Joplin, Missouri, United States, 64804 | |
Contact: Site Public Contact 417-347-4030 LJCrockett@freemanhealth.com | |
Principal Investigator: Jay W. Carlson | |
Mercy Hospital Joplin | Recruiting |
Joplin, Missouri, United States, 64804 | |
Contact: Site Public Contact 417-556-3074 esmeralda.carrillo@mercy.net | |
Principal Investigator: Jay W. Carlson | |
Delbert Day Cancer Institute at PCRMC | Recruiting |
Rolla, Missouri, United States, 65401 | |
Contact: Site Public Contact 573-458-8776 kaysmith@phelpshealth.org | |
Principal Investigator: Jay W. Carlson | |
Mercy Clinic-Rolla-Cancer and Hematology | Recruiting |
Rolla, Missouri, United States, 65401 | |
Contact: Site Public Contact 573-458-6379 | |
Principal Investigator: Jay W. Carlson | |
Heartland Regional Medical Center | Recruiting |
Saint Joseph, Missouri, United States, 64506 | |
Contact: Site Public Contact 816-271-7937 linda.schumacher@mymlc.com | |
Principal Investigator: Jay W. Carlson | |
Saint Louis Cancer and Breast Institute-South City | Recruiting |
Saint Louis, Missouri, United States, 63109 | |
Contact: Site Public Contact 314-353-1870 | |
Principal Investigator: Jay W. Carlson | |
Mercy Hospital South | Recruiting |
Saint Louis, Missouri, United States, 63128 | |
Contact: Site Public Contact janet.lesko@mercy.net | |
Principal Investigator: Jay W. Carlson | |
Missouri Baptist Medical Center | Recruiting |
Saint Louis, Missouri, United States, 63131 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Mercy Hospital Saint Louis | Recruiting |
Saint Louis, Missouri, United States, 63141 | |
Contact: Site Public Contact 314-251-7066 | |
Principal Investigator: Jay W. Carlson | |
Sainte Genevieve County Memorial Hospital | Recruiting |
Sainte Genevieve, Missouri, United States, 63670 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Mercy Hospital Springfield | Recruiting |
Springfield, Missouri, United States, 65804 | |
Contact: Site Public Contact 417-269-4520 | |
Principal Investigator: Jay W. Carlson | |
CoxHealth South Hospital | Recruiting |
Springfield, Missouri, United States, 65807 | |
Contact: Site Public Contact 417-269-4520 | |
Principal Investigator: Jay W. Carlson | |
Missouri Baptist Sullivan Hospital | Recruiting |
Sullivan, Missouri, United States, 63080 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Missouri Baptist Outpatient Center-Sunset Hills | Recruiting |
Sunset Hills, Missouri, United States, 63127 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Mercy Hospital Washington | Recruiting |
Washington, Missouri, United States, 63090 | |
Contact: Site Public Contact 636-390-1600 | |
Principal Investigator: Jay W. Carlson | |
United States, Montana | |
Community Hospital of Anaconda | Recruiting |
Anaconda, Montana, United States, 59711 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Billings Clinic Cancer Center | Recruiting |
Billings, Montana, United States, 59101 | |
Contact: Site Public Contact 800-996-2663 research@billingsclinic.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Vincent Healthcare | Suspended |
Billings, Montana, United States, 59101 | |
Saint Vincent Frontier Cancer Center | Suspended |
Billings, Montana, United States, 59102 | |
Bozeman Deaconess Hospital | Recruiting |
Bozeman, Montana, United States, 59715 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Benefis Healthcare- Sletten Cancer Institute | Recruiting |
Great Falls, Montana, United States, 59405 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Great Falls Clinic | Recruiting |
Great Falls, Montana, United States, 59405 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Kalispell Regional Medical Center | Recruiting |
Kalispell, Montana, United States, 59901 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Patrick Hospital - Community Hospital | Recruiting |
Missoula, Montana, United States, 59802 | |
Contact: Site Public Contact 406-327-3118 amy.hanneman@providence.org | |
Principal Investigator: Alison K. Conlin | |
Community Medical Hospital | Recruiting |
Missoula, Montana, United States, 59804 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
United States, Nebraska | |
Nebraska Medicine-Bellevue | Recruiting |
Bellevue, Nebraska, United States, 68123 | |
Contact: Site Public Contact 402-559-6941 unmcrsa@unmc.edu | |
Principal Investigator: Laxmi Narayana R. Buddharaju | |
CHI Health Saint Francis | Recruiting |
Grand Island, Nebraska, United States, 68803 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
CHI Health Good Samaritan | Recruiting |
Kearney, Nebraska, United States, 68847 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Elizabeth Regional Medical Center | Recruiting |
Lincoln, Nebraska, United States, 68510 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Nebraska Methodist Hospital | Recruiting |
Omaha, Nebraska, United States, 68114 | |
Contact: Site Public Contact 402-354-5144 | |
Principal Investigator: Timothy Dorius | |
Nebraska Medicine-Village Pointe | Recruiting |
Omaha, Nebraska, United States, 68118 | |
Contact: Site Public Contact 402-559-5600 | |
Principal Investigator: Laxmi Narayana R. Buddharaju | |
Alegent Health Immanuel Medical Center | Recruiting |
Omaha, Nebraska, United States, 68122 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Alegent Health Bergan Mercy Medical Center | Recruiting |
Omaha, Nebraska, United States, 68124 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Alegent Health Lakeside Hospital | Recruiting |
Omaha, Nebraska, United States, 68130 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Creighton University Medical Center | Recruiting |
Omaha, Nebraska, United States, 68131 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
University of Nebraska Medical Center | Recruiting |
Omaha, Nebraska, United States, 68198 | |
Contact: Site Public Contact 402-559-6941 unmcrsa@unmc.edu | |
Principal Investigator: Laxmi Narayana R. Buddharaju | |
Midlands Community Hospital | Recruiting |
Papillion, Nebraska, United States, 68046 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, Nevada | |
Carson Tahoe Regional Medical Center | Recruiting |
Carson City, Nevada, United States, 89703 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Cancer and Blood Specialists-Henderson | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada - Henderson | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada-Horizon Ridge | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Cancer Center-Henderson | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
OptumCare Cancer Care at Seven Hills | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
21st Century Oncology-Henderson | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada-Southeast Henderson | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Green Valley | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Pebble | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Urology Specialists of Nevada - Green Valley | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Pecos | Recruiting |
Las Vegas, Nevada, United States, 89074 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Desert West Surgery | Recruiting |
Las Vegas, Nevada, United States, 89102 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
OptumCare Cancer Care at Charleston | Recruiting |
Las Vegas, Nevada, United States, 89102 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
University Medical Center of Southern Nevada | Recruiting |
Las Vegas, Nevada, United States, 89102 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Hope Cancer Care of Nevada | Recruiting |
Las Vegas, Nevada, United States, 89103 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Cancer and Blood Specialists-Shadow | Suspended |
Las Vegas, Nevada, United States, 89106 | |
Radiation Oncology Centers of Nevada Central | Recruiting |
Las Vegas, Nevada, United States, 89106 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Urology Specialists of Nevada - Central | Recruiting |
Las Vegas, Nevada, United States, 89106 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
21st Century Oncology | Recruiting |
Las Vegas, Nevada, United States, 89109 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway | Suspended |
Las Vegas, Nevada, United States, 89109 | |
Sunrise Hospital and Medical Center | Recruiting |
Las Vegas, Nevada, United States, 89109 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
HealthCare Partners Medical Group Oncology/Hematology-San Martin | Suspended |
Las Vegas, Nevada, United States, 89113 | |
Las Vegas Prostate Cancer Center | Recruiting |
Las Vegas, Nevada, United States, 89113 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Sunset | Recruiting |
Las Vegas, Nevada, United States, 89113 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Radiation Oncology Centers of Nevada Southeast | Recruiting |
Las Vegas, Nevada, United States, 89119 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
21st Century Oncology-Vegas Tenaya | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Ann M Wierman MD LTD | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Cancer and Blood Specialists-Tenaya | Suspended |
Las Vegas, Nevada, United States, 89128 | |
Comprehensive Cancer Centers of Nevada - Northwest | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
HealthCare Partners Medical Group Oncology/Hematology-Tenaya | Suspended |
Las Vegas, Nevada, United States, 89128 | |
Las Vegas Urology - Cathedral Rock | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Smoke Ranch | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact research@smcrf.org | |
Principal Investigator: John A. Ellerton | |
OptumCare Cancer Care at MountainView | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Urology Specialists of Nevada - Northwest | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Alliance for Childhood Diseases/Cure 4 the Kids Foundation | Recruiting |
Las Vegas, Nevada, United States, 89135 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada - Town Center | Recruiting |
Las Vegas, Nevada, United States, 89144 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada-Summerlin | Recruiting |
Las Vegas, Nevada, United States, 89144 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Summerlin Hospital Medical Center | Recruiting |
Las Vegas, Nevada, United States, 89144 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Cancer Center-Medical Center | Recruiting |
Las Vegas, Nevada, United States, 89148-2405 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
21st Century Oncology-Fort Apache | Recruiting |
Las Vegas, Nevada, United States, 89148 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada | Recruiting |
Las Vegas, Nevada, United States, 89148 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
OptumCare Cancer Care at Fort Apache | Recruiting |
Las Vegas, Nevada, United States, 89148 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Urology Specialists of Nevada - Southwest | Recruiting |
Las Vegas, Nevada, United States, 89148 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills | Suspended |
Las Vegas, Nevada, United States, 89149 | |
Comprehensive Cancer Centers of Nevada - Central Valley | Recruiting |
Las Vegas, Nevada, United States, 89169 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
University Cancer Center | Recruiting |
Las Vegas, Nevada, United States, 89169 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Hope Cancer Care of Nevada-Pahrump | Recruiting |
Pahrump, Nevada, United States, 89048 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Renown Regional Medical Center | Recruiting |
Reno, Nevada, United States, 89502 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Saint Mary's Regional Medical Center | Recruiting |
Reno, Nevada, United States, 89503 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Radiation Oncology Associates | Recruiting |
Reno, Nevada, United States, 89509 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
United States, New Hampshire | |
New Hampshire Oncology Hematology PA-Concord | Recruiting |
Concord, New Hampshire, United States, 03301 | |
Contact: Site Public Contact 603-224-2556 | |
Principal Investigator: Douglas J. Weckstein | |
Elliot Hospital | Active, not recruiting |
Manchester, New Hampshire, United States, 03103 | |
Solinsky Center for Cancer Care | Recruiting |
Manchester, New Hampshire, United States, 03103 | |
Contact: Site Public Contact 800-339-6484 | |
Principal Investigator: Douglas J. Weckstein | |
United States, New Jersey | |
Virtua Samson Cancer Center | Recruiting |
Moorestown, New Jersey, United States, 08057 | |
Contact: Site Public Contact 856-247-7395 | |
Principal Investigator: James W. Lee | |
Virtua Memorial | Recruiting |
Mount Holly, New Jersey, United States, 08060 | |
Contact: Site Public Contact 609-914-6762 | |
Principal Investigator: James W. Lee | |
Virtua Voorhees | Recruiting |
Voorhees, New Jersey, United States, 08043 | |
Contact: Site Public Contact 856-247-7395 | |
Principal Investigator: James W. Lee | |
United States, New Mexico | |
University of New Mexico Cancer Center | Recruiting |
Albuquerque, New Mexico, United States, 87102 | |
Contact: Site Public Contact 505-925-0366 LByatt@nmcca.org | |
Principal Investigator: Atul Kumar | |
United States, New York | |
Montefiore Medical Center-Einstein Campus | Recruiting |
Bronx, New York, United States, 10461 | |
Contact: Site Public Contact 718-379-6866 eskwak@montefiore.org | |
Principal Investigator: Haiying Cheng | |
Montefiore Medical Center-Weiler Hospital | Recruiting |
Bronx, New York, United States, 10461 | |
Contact: Site Public Contact 718-379-6866 eskwak@montefiore.org | |
Principal Investigator: Haiying Cheng | |
Montefiore Medical Center - Moses Campus | Recruiting |
Bronx, New York, United States, 10467 | |
Contact: Site Public Contact 718-379-6866 eskwak@montefiore.org | |
Principal Investigator: Haiying Cheng | |
Glens Falls Hospital | Recruiting |
Glens Falls, New York, United States, 12801 | |
Contact: Site Public Contact 518-926-6700 | |
Principal Investigator: Aqeel A. Gillani | |
United States, North Carolina | |
Vidant Oncology-Kenansville | Recruiting |
Kenansville, North Carolina, United States, 28349 | |
Contact: Site Public Contact 252-559-2201 Carla.Zimmerman@vidanthealth.com | |
Principal Investigator: Misbah U. Qadir | |
Vidant Oncology-Kinston | Recruiting |
Kinston, North Carolina, United States, 28501 | |
Contact: Site Public Contact 252-559-2201 Carla.Zimmerman@vidanthealth.com | |
Principal Investigator: Misbah U. Qadir | |
FirstHealth of the Carolinas-Moore Regional Hospital | Recruiting |
Pinehurst, North Carolina, United States, 28374 | |
Contact: Site Public Contact 910-715-3500 jcwilliams@firsthealth.org | |
Principal Investigator: Charles S. Kuzma | |
Vidant Oncology-Richlands | Recruiting |
Richlands, North Carolina, United States, 28574 | |
Contact: Site Public Contact 252-559-2201 Carla.Zimmerman@vidanthealth.com | |
Principal Investigator: Misbah U. Qadir | |
Marion L Shepard Cancer Center at Vidant Beaufort Hospital | Recruiting |
Washington, North Carolina, United States, 27889 | |
Contact: Site Public Contact 252-975-4308 | |
Principal Investigator: Vijay Chaudhary | |
United States, North Dakota | |
Essentia Health Cancer Center-South University Clinic | Recruiting |
Fargo, North Dakota, United States, 58103 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health - Jamestown Clinic | Recruiting |
Jamestown, North Dakota, United States, 58401 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
United States, Ohio | |
Aultman Alliance Community Hospital | Recruiting |
Alliance, Ohio, United States, 44601 | |
Contact: Site Public Contact 330-363-1250 | |
Principal Investigator: Sunitha Vemulapalli | |
Indu and Raj Soin Medical Center | Recruiting |
Beavercreek, Ohio, United States, 45431 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Saint Elizabeth Boardman Hospital | Recruiting |
Boardman, Ohio, United States, 44512 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Mercy Hematology and Oncology Associates Inc | Recruiting |
Canton, Ohio, United States, 44708 | |
Contact: Site Public Contact 330-453-9993 | |
Principal Investigator: Mitchell Haut | |
Mercy Medical Center | Recruiting |
Canton, Ohio, United States, 44708 | |
Contact: Site Public Contact 888-293-4673 | |
Principal Investigator: Mitchell Haut | |
Aultman Health Foundation | Recruiting |
Canton, Ohio, United States, 44710 | |
Contact: Site Public Contact 330-363-7274 ClinicalReserachDept@aultman.com | |
Principal Investigator: Sunitha Vemulapalli | |
Dayton Physicians LLC-Miami Valley South | Recruiting |
Centerville, Ohio, United States, 45459 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Miami Valley Hospital South | Recruiting |
Centerville, Ohio, United States, 45459 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Good Samaritan Hospital - Cincinnati | Recruiting |
Cincinnati, Ohio, United States, 45220 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Oncology Hematology Care Inc-Kenwood | Recruiting |
Cincinnati, Ohio, United States, 45236 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Bethesda North Hospital | Recruiting |
Cincinnati, Ohio, United States, 45242 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
TriHealth Cancer Institute-Westside | Recruiting |
Cincinnati, Ohio, United States, 45247 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
TriHealth Cancer Institute-Anderson | Recruiting |
Cincinnati, Ohio, United States, 45255 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Miami Valley Hospital | Recruiting |
Dayton, Ohio, United States, 45409 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Dayton Physician LLC-Miami Valley Hospital North | Recruiting |
Dayton, Ohio, United States, 45415 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Miami Valley Hospital North | Recruiting |
Dayton, Ohio, United States, 45415 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Armes Family Cancer Center | Recruiting |
Findlay, Ohio, United States, 45840 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Blanchard Valley Hospital | Recruiting |
Findlay, Ohio, United States, 45840 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Orion Cancer Care | Recruiting |
Findlay, Ohio, United States, 45840 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Atrium Medical Center-Middletown Regional Hospital | Recruiting |
Franklin, Ohio, United States, 45005-1066 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Dayton Physicians LLC-Atrium | Recruiting |
Franklin, Ohio, United States, 45005 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Dayton Physicians LLC-Wayne | Recruiting |
Greenville, Ohio, United States, 45331 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Wayne Hospital | Recruiting |
Greenville, Ohio, United States, 45331 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Greater Dayton Cancer Center | Recruiting |
Kettering, Ohio, United States, 45409 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
First Dayton Cancer Care | Suspended |
Kettering, Ohio, United States, 45420 | |
Kettering Medical Center | Recruiting |
Kettering, Ohio, United States, 45429 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Mercy Health Perrysburg Cancer Center | Suspended |
Perrysburg, Ohio, United States, 43551 | |
Springfield Regional Cancer Center | Recruiting |
Springfield, Ohio, United States, 45504 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Springfield Regional Medical Center | Recruiting |
Springfield, Ohio, United States, 45505 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Mercy Health - Saint Anne Hospital | Recruiting |
Toledo, Ohio, United States, 43623 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Rex B. Mowat | |
Toledo Clinic Cancer Centers-Toledo | Recruiting |
Toledo, Ohio, United States, 43623 | |
Contact: Site Public Contact 800-444-3561 | |
Principal Investigator: Rex B. Mowat | |
Dayton Physicians LLC-Upper Valley | Recruiting |
Troy, Ohio, United States, 45373 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Upper Valley Medical Center | Recruiting |
Troy, Ohio, United States, 45373 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Saint Joseph Warren Hospital | Recruiting |
Warren, Ohio, United States, 44484 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Wright-Patterson Medical Center | Recruiting |
Wright-Patterson Air Force Base, Ohio, United States, 45433 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Florin D. Andreca | |
Saint Elizabeth Youngstown Hospital | Recruiting |
Youngstown, Ohio, United States, 44501 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
United States, Oklahoma | |
Mercy Hospital Oklahoma City | Recruiting |
Oklahoma City, Oklahoma, United States, 73120 | |
Contact: Site Public Contact 405-752-3402 | |
Principal Investigator: Jay W. Carlson | |
United States, Oregon | |
Saint Alphonsus Medical Center-Baker City | Recruiting |
Baker City, Oregon, United States, 97814 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Charles Health System | Recruiting |
Bend, Oregon, United States, 97701 | |
Contact: Site Public Contact 541-706-2909 nosall@stcharleshealthcare.org | |
Principal Investigator: Alison K. Conlin | |
Clackamas Radiation Oncology Center | Recruiting |
Clackamas, Oregon, United States, 97015 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Cancer Institute Clackamas Clinic | Recruiting |
Clackamas, Oregon, United States, 97015 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Bay Area Hospital | Recruiting |
Coos Bay, Oregon, United States, 97420 | |
Contact: Site Public Contact 541-269-8392 cherie.cox@bayareahospital.org | |
Principal Investigator: Alison K. Conlin | |
Providence Newberg Medical Center | Recruiting |
Newberg, Oregon, United States, 97132 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Saint Alphonsus Medical Center-Ontario | Recruiting |
Ontario, Oregon, United States, 97914 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Providence Portland Medical Center | Recruiting |
Portland, Oregon, United States, 97213 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Saint Vincent Medical Center | Recruiting |
Portland, Oregon, United States, 97225 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Oregon Health and Science University | Recruiting |
Portland, Oregon, United States, 97239 | |
Contact: Site Public Contact 503-494-1080 trials@ohsu.edu | |
Principal Investigator: Jeremy P. Cetnar | |
Saint Charles Health System-Redmond | Recruiting |
Redmond, Oregon, United States, 97756 | |
Contact: Site Public Contact 541-706-2909 | |
Principal Investigator: Alison K. Conlin | |
United States, Pennsylvania | |
Lehigh Valley Hospital-Cedar Crest | Recruiting |
Allentown, Pennsylvania, United States, 18103 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Lehigh Valley Hospital - Muhlenberg | Recruiting |
Bethlehem, Pennsylvania, United States, 18017 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Bryn Mawr Hospital | Recruiting |
Bryn Mawr, Pennsylvania, United States, 19010 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Chambersburg Hospital | Recruiting |
Chambersburg, Pennsylvania, United States, 17201 | |
Contact: Site Public Contact 888-823-5923 ctsucontact@westat.com | |
Principal Investigator: Joseph Kannarkatt | |
Main Line Health Center-Collegeville | Recruiting |
Collegeville, Pennsylvania, United States, 19426 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Pocono Medical Center | Recruiting |
East Stroudsburg, Pennsylvania, United States, 18301 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Ephrata Cancer Center | Recruiting |
Ephrata, Pennsylvania, United States, 17522 | |
Contact: Site Public Contact 717-721-4840 | |
Principal Investigator: Joseph Kannarkatt | |
Main Line Health Center-Exton | Recruiting |
Exton, Pennsylvania, United States, 19341 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Adams Cancer Center | Recruiting |
Gettysburg, Pennsylvania, United States, 17325 | |
Contact: Site Public Contact 877-441-7957 | |
Principal Investigator: Joseph Kannarkatt | |
Cherry Tree Cancer Center | Recruiting |
Hanover, Pennsylvania, United States, 17331 | |
Contact: Site Public Contact 877-441-7957 | |
Principal Investigator: Joseph Kannarkatt | |
Lehigh Valley Hospital-Hazleton | Recruiting |
Hazleton, Pennsylvania, United States, 18201 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Sechler Family Cancer Center | Recruiting |
Lebanon, Pennsylvania, United States, 17042 | |
Contact: Site Public Contact 717-741-8303 doxenberg@wellspan.org | |
Principal Investigator: Joseph Kannarkatt | |
Riddle Memorial Hospital | Recruiting |
Media, Pennsylvania, United States, 19063 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Bryn Mawr Health Center | Recruiting |
Newtown Square, Pennsylvania, United States, 19073 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Paoli Memorial Hospital | Recruiting |
Paoli, Pennsylvania, United States, 19301 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Pottstown Hospital | Recruiting |
Pottstown, Pennsylvania, United States, 19464 | |
Contact: Site Public Contact 610-327-7544 | |
Principal Investigator: Wei Song | |
Lankenau Medical Center | Recruiting |
Wynnewood, Pennsylvania, United States, 19096 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
WellSpan Health-York Cancer Center | Recruiting |
York, Pennsylvania, United States, 17403 | |
Contact: Site Public Contact 877-441-7957 | |
Principal Investigator: Joseph Kannarkatt | |
WellSpan Health-York Hospital | Recruiting |
York, Pennsylvania, United States, 17403 | |
Contact: Site Public Contact 877-441-7957 | |
Principal Investigator: Joseph Kannarkatt | |
United States, South Carolina | |
Self Regional Healthcare | Recruiting |
Greenwood, South Carolina, United States, 29646 | |
Contact: Site Public Contact 864-725-4771 nmcgaha@selfregional.org | |
Principal Investigator: Carol A. Sherman | |
United States, Texas | |
Saint Joseph Regional Cancer Center | Recruiting |
Bryan, Texas, United States, 77802 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, Virginia | |
Bon Secours Memorial Regional Medical Center | Recruiting |
Mechanicsville, Virginia, United States, 23116 | |
Contact: Site Public Contact 804-893-8663 Jaime_scott@bshsi.org | |
Principal Investigator: William J. Irvin | |
Bon Secours Saint Francis Medical Center | Recruiting |
Midlothian, Virginia, United States, 23114 | |
Contact: Site Public Contact 804-893-8663 Jaime_scott@bshsi.org | |
Principal Investigator: William J. Irvin | |
Bon Secours DePaul Medical Center | Recruiting |
Norfolk, Virginia, United States, 23505 | |
Contact: Site Public Contact 804-893-8663 Jaime_scott@bshsi.org | |
Principal Investigator: William J. Irvin | |
Bon Secours Maryview Medical Center | Recruiting |
Portsmouth, Virginia, United States, 23707 | |
Contact: Site Public Contact 804-893-8663 Jaime_scott@bshsi.org | |
Principal Investigator: William J. Irvin | |
Bon Secours Saint Mary's Hospital | Recruiting |
Richmond, Virginia, United States, 23226 | |
Contact: Site Public Contact 804-893-8663 Jaime_scott@bshsi.org | |
Principal Investigator: William J. Irvin | |
Bon Secours Cancer Institute at Reynolds Crossing | Recruiting |
Richmond, Virginia, United States, 23230 | |
Contact: Site Public Contact 804-893-8663 Jaime_scott@bshsi.org | |
Principal Investigator: William J. Irvin | |
Bon Secours Health Center at Harbour View | Recruiting |
Suffolk, Virginia, United States, 23435 | |
Contact: Site Public Contact 804-893-8663 Jaime_scott@bshsi.org | |
Principal Investigator: William J. Irvin | |
United States, Washington | |
Providence Regional Cancer System-Aberdeen | Recruiting |
Aberdeen, Washington, United States, 98520 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
Overlake Medical Center | Recruiting |
Bellevue, Washington, United States, 98004 | |
Contact: Site Public Contact 425-688-5407 OHMCResearch@overlakehospital.org | |
Principal Investigator: John A. Ellerton | |
PeaceHealth Saint Joseph Medical Center | Recruiting |
Bellingham, Washington, United States, 98225 | |
Contact: Site Public Contact 360-788-8238 lkey@peacehealth.org | |
Principal Investigator: Alison K. Conlin | |
Harrison HealthPartners Hematology and Oncology-Bremerton | Recruiting |
Bremerton, Washington, United States, 98310 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Harrison Medical Center | Recruiting |
Bremerton, Washington, United States, 98310 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Highline Medical Center-Main Campus | Recruiting |
Burien, Washington, United States, 98166 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Providence Regional Cancer System-Centralia | Recruiting |
Centralia, Washington, United States, 98531 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
Swedish Cancer Institute-Edmonds | Recruiting |
Edmonds, Washington, United States, 98026 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Saint Elizabeth Hospital | Recruiting |
Enumclaw, Washington, United States, 98022 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Providence Regional Cancer Partnership | Recruiting |
Everett, Washington, United States, 98201 | |
Contact: Site Public Contact 425-261-3529 marilyn.birchman@providence.org | |
Principal Investigator: Alison K. Conlin | |
Saint Francis Hospital | Recruiting |
Federal Way, Washington, United States, 98003 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Swedish Cancer Institute-Issaquah | Recruiting |
Issaquah, Washington, United States, 98029 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Kadlec Clinic Hematology and Oncology | Recruiting |
Kennewick, Washington, United States, 99336 | |
Contact: Site Public Contact 509-783-4637 research@kadlecmed.org | |
Principal Investigator: Alison K. Conlin | |
Providence Regional Cancer System-Lacey | Recruiting |
Lacey, Washington, United States, 98503 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
Saint Clare Hospital | Recruiting |
Lakewood, Washington, United States, 98499 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
PeaceHealth Saint John Medical Center | Recruiting |
Longview, Washington, United States, 98632 | |
Contact: Site Public Contact 360-514-2016 kmakin-bond@peacehealth.org | |
Principal Investigator: Alison K. Conlin | |
Jefferson Healthcare | Recruiting |
Port Townsend, Washington, United States, 98368 | |
Contact: Site Public Contact 360-344-3091 | |
Principal Investigator: Nicholas DiBella | |
Harrison HealthPartners Hematology and Oncology-Poulsbo | Recruiting |
Poulsbo, Washington, United States, 98370 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Valley Medical Center | Recruiting |
Renton, Washington, United States, 98055 | |
Contact: Site Public Contact 425-228-3440 research@valleymed.org | |
Principal Investigator: John A. Ellerton | |
Pacific Gynecology Specialists | Recruiting |
Seattle, Washington, United States, 98104 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Swedish Medical Center-Ballard Campus | Recruiting |
Seattle, Washington, United States, 98107 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Swedish Medical Center-First Hill | Recruiting |
Seattle, Washington, United States, 98122-4307 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Swedish Medical Center-Cherry Hill | Recruiting |
Seattle, Washington, United States, 98122-5711 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
PeaceHealth United General Medical Center | Recruiting |
Sedro-Woolley, Washington, United States, 98284 | |
Contact: Site Public Contact 360-788-8238 lkey@peacehealth.org | |
Principal Investigator: Alison K. Conlin | |
Providence Regional Cancer System-Shelton | Recruiting |
Shelton, Washington, United States, 98584 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
Franciscan Research Center-Northwest Medical Plaza | Recruiting |
Tacoma, Washington, United States, 98405 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Northwest Medical Specialties PLLC | Recruiting |
Tacoma, Washington, United States, 98405 | |
Contact: Site Public Contact 253-306-0532 research@southsoundcare.org | |
Principal Investigator: Richard L. Deming | |
PeaceHealth Southwest Medical Center | Recruiting |
Vancouver, Washington, United States, 98664 | |
Contact: Site Public Contact 360-514-3940 kmakin-bond@peacehealth.org | |
Principal Investigator: Alison K. Conlin | |
Providence Saint Mary Regional Cancer Center | Recruiting |
Walla Walla, Washington, United States, 99362 | |
Contact: Site Public Contact 509-897-5993 Cheryl.Dodd@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Regional Cancer System-Yelm | Recruiting |
Yelm, Washington, United States, 98597 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
United States, Wisconsin | |
ThedaCare Regional Cancer Center | Recruiting |
Appleton, Wisconsin, United States, 54911 | |
Contact: Site Public Contact 920-364-3605 ResearchDept@thedacare.org | |
Principal Investigator: William A. Conkright | |
Duluth Clinic Ashland | Recruiting |
Ashland, Wisconsin, United States, 54806 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Northwest Wisconsin Cancer Center | Recruiting |
Ashland, Wisconsin, United States, 54806 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Aurora Cancer Care-Southern Lakes VLCC | Recruiting |
Burlington, Wisconsin, United States, 53105 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Shamsuddin Virani | |
Marshfield Clinic-Chippewa Center | Suspended |
Chippewa Falls, Wisconsin, United States, 54729 | |
Aurora Saint Luke's South Shore | Recruiting |
Cudahy, Wisconsin, United States, 53110 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Shamsuddin Virani | |
Marshfield Medical Center-EC Cancer Center | Suspended |
Eau Claire, Wisconsin, United States, 54701 | |
Aurora Health Care Germantown Health Center | Recruiting |
Germantown, Wisconsin, United States, 53022 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Shamsuddin Virani | |
Aurora Cancer Care-Grafton | Recruiting |
Grafton, Wisconsin, United States, 53024 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Shamsuddin Virani | |
Aurora BayCare Medical Center | Recruiting |
Green Bay, Wisconsin, United States, 54311 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Shamsuddin Virani | |
Aurora Cancer Care-Kenosha South | Recruiting |
Kenosha, Wisconsin, United States, 53142 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Shamsuddin Virani | |
Gundersen Lutheran Medical Center | Recruiting |
La Crosse, Wisconsin, United States, 54601 | |
Contact: Site Public Contact 608-775-2385 cancerctr@gundersenhealth.org | |
Principal Investigator: Kurt Oettel | |
Marshfield Clinic - Ladysmith Center | Suspended |
Ladysmith, Wisconsin, United States, 54848 | |
Aurora Bay Area Medical Group-Marinette | Recruiting |
Marinette, Wisconsin, United States, 54143 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Shamsuddin Virani | |
Marshfield Medical Center-Marshfield | Suspended |
Marshfield, Wisconsin, United States, 54449 | |
Aurora Cancer Care-Milwaukee | Recruiting |
Milwaukee, Wisconsin, United States, 53209 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Shamsuddin Virani | |
Aurora Saint Luke's Medical Center | Recruiting |
Milwaukee, Wisconsin, United States, 53215 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Shamsuddin Virani | |
Aurora Sinai Medical Center | Recruiting |
Milwaukee, Wisconsin, United States, 53233 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Shamsuddin Virani | |
Marshfield Clinic-Minocqua Center | Suspended |
Minocqua, Wisconsin, United States, 54548 | |
ProHealth D N Greenwald Center | Recruiting |
Mukwonago, Wisconsin, United States, 53149 | |
Contact: Site Public Contact research.institute@phci.org | |
Principal Investigator: Timothy R. Wassenaar | |
Cancer Center of Western Wisconsin | Recruiting |
New Richmond, Wisconsin, United States, 54017 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
ProHealth Oconomowoc Memorial Hospital | Recruiting |
Oconomowoc, Wisconsin, United States, 53066 | |
Contact: Site Public Contact 262-928-7878 | |
Principal Investigator: Timothy R. Wassenaar | |
Vince Lombardi Cancer Clinic - Oshkosh | Recruiting |
Oshkosh, Wisconsin, United States, 54904 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Shamsuddin Virani | |
Aurora Cancer Care-Racine | Recruiting |
Racine, Wisconsin, United States, 53406 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Shamsuddin Virani | |
Vince Lombardi Cancer Clinic-Sheboygan | Recruiting |
Sheboygan, Wisconsin, United States, 53081 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Shamsuddin Virani | |
Marshfield Clinic Stevens Point Center | Suspended |
Stevens Point, Wisconsin, United States, 54482 | |
Aurora Medical Center in Summit | Recruiting |
Summit, Wisconsin, United States, 53066 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Shamsuddin Virani | |
Vince Lombardi Cancer Clinic-Two Rivers | Recruiting |
Two Rivers, Wisconsin, United States, 54241 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Shamsuddin Virani | |
ProHealth Waukesha Memorial Hospital | Recruiting |
Waukesha, Wisconsin, United States, 53188 | |
Contact: Site Public Contact 262-928-7632 | |
Principal Investigator: Timothy R. Wassenaar | |
UW Cancer Center at ProHealth Care | Recruiting |
Waukesha, Wisconsin, United States, 53188 | |
Contact: Site Public Contact 262-928-5539 Chanda.miller@phci.org | |
Principal Investigator: Timothy R. Wassenaar | |
Marshfield Clinic-Wausau Center | Suspended |
Wausau, Wisconsin, United States, 54401 | |
Aurora Cancer Care-Milwaukee West | Recruiting |
Wauwatosa, Wisconsin, United States, 53226 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Shamsuddin Virani | |
Marshfield Medical Center - Weston | Suspended |
Weston, Wisconsin, United States, 54476 | |
Marshfield Clinic - Wisconsin Rapids Center | Suspended |
Wisconsin Rapids, Wisconsin, United States, 54494 | |
United States, Wyoming | |
Cheyenne Regional Medical Center-West | Recruiting |
Cheyenne, Wyoming, United States, 82001 | |
Contact: Site Public Contact 303-777-2663 ccrp@co-cancerresearch.org | |
Principal Investigator: Nicholas DiBella | |
Billings Clinic-Cody | Recruiting |
Cody, Wyoming, United States, 82414 | |
Contact: Site Public Contact 800-996-2663 research@billingsclinic.org | |
Principal Investigator: John M. Schallenkamp | |
Welch Cancer Center | Recruiting |
Sheridan, Wyoming, United States, 82801 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp |
Principal Investigator: | Joel W Neal | ECOG-ACRIN Cancer Research Group |
Responsible Party: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT04310007 |
Other Study ID Numbers: |
NCI-2020-01541 NCI-2020-01541 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) ) EA5191 ( Other Identifier: ECOG-ACRIN Cancer Research Group ) EA5191 ( Other Identifier: CTEP ) U10CA180820 ( U.S. NIH Grant/Contract ) |
First Posted: | March 17, 2020 Key Record Dates |
Last Update Posted: | April 12, 2021 |
Last Verified: | April 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page. |
URL: | https://grants.nih.gov/policy/sharing.htm |
Studies a U.S. FDA-regulated Drug Product: | Yes |
Studies a U.S. FDA-regulated Device Product: | No |
Carcinoma Lung Neoplasms Carcinoma, Non-Small-Cell Lung Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms by Site Lung Diseases Respiratory Tract Diseases Carcinoma, Bronchogenic Bronchial Neoplasms Gemcitabine Paclitaxel |
Docetaxel Albumin-Bound Paclitaxel Nivolumab Ramucirumab Antineoplastic Agents, Immunological Antibodies Immunoglobulins Antibodies, Monoclonal Antineoplastic Agents, Phytogenic Antineoplastic Agents Tubulin Modulators Antimitotic Agents Mitosis Modulators Molecular Mechanisms of Pharmacological Action Immunologic Factors |